期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Hereditary Cancer in Clinical Practice LetPub Score 4.9
50 ratings
Rate
Reputation 5.8 Influence 3.7 Speed 7.0 | ||||||||||||||||||||
期刊簡稱 | HERED CANCER CLIN PR | ||||||||||||||||||||
ISSN | 1731-2302 | ||||||||||||||||||||
E-ISSN | 1897-4287 | ||||||||||||||||||||
h-index | 21 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 5.00%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://hccpjournal.biomedcentral.com | ||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/hccp | ||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||
出版商 | BioMed Central | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | POLAND | ||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||
創刊年 | 2003 | ||||||||||||||||||||
每年文章數 | 24每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 100.00% | ||||||||||||||||||||
OA Related Info | APC: Yes( GBP1890; USD2590; EUR2190; ) APC waiver:Check Notes Other charges: No Keywords: cancer genetics Useful LinksAims & ScopeAuthor InstructionsEditorial BoardOpen peer review | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1731-2302%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: >12 Week(s), or Invited contributions | ||||||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Hereditary Cancer in Clinical Practice] 的評論 | 撰寫評論 |
作者: 文雯公子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-22 20:34:05 評論於 Review Speed: 6.0 | Submission Hit Rate: 75.0 Experience Sharing: The review process is fast, the editors are very tolerant, and there were hardly any questions asked. Publishing and rights complete: 16 Feb 2024 Submission is in publishing and rights: 15 Feb 2024 Peer review Submission status Date Submission accepted: 13 Feb 2024 Submission under peer review: 22 Jan 2024 Submission passed technical check: 22 Jan 2024 Revision received: 22 Jan 2024 Submission under peer review: 10 Oct 2023 Technical check Submission status Date Submission passed technical check: 10 Oct 2023 Amendment received: 06 Oct 2023 Submission is under technical check: 03 Oct 2023 Submission received Submission status Date Submission received: 03 Oct 2023(0) 讚! | 文雯公子 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:42:52 評論於 Not all journals require this item to be filled out(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:01:20 評論於 RUNNING TITLE is shorter and typically printed in the header of published articles(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 破戒阳平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 23:59:37 評論於 Is a running title necessary?(0) 讚! | 破戒阳平 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 17:18:46 評論於 What is the difference between RUNNINGTITLE and TITLE?(0) 讚! | 八坂篷蔚 |
作者: Violet Bart 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-10-14 12:03:06 評論於 It's been 2 months, finally under review, how slow is the pace(0) 讚! | Violet Bart |
作者: Violet Bart 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-09-10 23:48:41 評論於 There is no news yet, it's been almost a month, and the editor is still assigned(0) 讚! | Violet Bart |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us